The Levels of P Expression (MFI values) for CTL (CD3+P+) and Their Subpopulations (CD4+P+ and CD8+P+), and NK Subpopulations (CD16+P+ and CD56+P+) in CB Lymphocytes and PBL From Children, Men, Women, and Elderly Persons
| Group . | No. . | CD3+P+ . | CD4+P+ . | CD8+P+ . | CD16+P+ . | CD56+P+ . |
|---|---|---|---|---|---|---|
| (A) CB | 5 | 46.4 ± 11.5 | 19.4 ± 9.2 | 47.1 ± 11.0 | 50.1 ± 9.8 | 61.9 ± 14.1 |
| (B) C | 7 | 43.3 ± 7.6 | 27.8 ± 2.1 | 44.4 ± 12.4 | 51.3 ± 5.7 | 51.1 ± 6.3 |
| (C) M | 9 | 26.1 ± 2.5 | 27.9 ± 3.5 | 37.1 ± 3.2 | 51.8 ± 6.6 | 51.6 ± 5.9 |
| (D) W | 12 | 42.6 ± 6.2 | 54.5 ± 18.1 | 60.3 ± 16.2 | 112.3 ± 28.6 | 66.9 ± 11.2 |
| (E) O | 7 | 11.8 ± 1.3 | 5.7 ± 0.7 | 7.9 ± 3.2 | 7.0 ± 1.2 | 8.7 ± 2.1 |
| Group . | No. . | CD3+P+ . | CD4+P+ . | CD8+P+ . | CD16+P+ . | CD56+P+ . |
|---|---|---|---|---|---|---|
| (A) CB | 5 | 46.4 ± 11.5 | 19.4 ± 9.2 | 47.1 ± 11.0 | 50.1 ± 9.8 | 61.9 ± 14.1 |
| (B) C | 7 | 43.3 ± 7.6 | 27.8 ± 2.1 | 44.4 ± 12.4 | 51.3 ± 5.7 | 51.1 ± 6.3 |
| (C) M | 9 | 26.1 ± 2.5 | 27.9 ± 3.5 | 37.1 ± 3.2 | 51.8 ± 6.6 | 51.6 ± 5.9 |
| (D) W | 12 | 42.6 ± 6.2 | 54.5 ± 18.1 | 60.3 ± 16.2 | 112.3 ± 28.6 | 66.9 ± 11.2 |
| (E) O | 7 | 11.8 ± 1.3 | 5.7 ± 0.7 | 7.9 ± 3.2 | 7.0 ± 1.2 | 8.7 ± 2.1 |
Levels of significance for MFI (from P < .05 toP < .001): CD3+P+ = (A, B, D) versus C; C versus E; (A, B, D) versus E; CD4+P+ = (B, C, D) versus (A, E); D versus (B, C) CD8+P+ = (A, B, C, D) versus E; CD16+P+ = D versus (A, B, C); (A, B, C, D) versus E; CD56+P+ = (A, B, C, D) versus E.